January 19, 2018 5:28 AM ET


Company Overview of Aviragen Therapeutics, Inc.

Executive Profile

Geoffrey F. Cox Ph.D., BSc

Non-Executive Independent Director, Aviragen Therapeutics, Inc.
AgeTotal Calculated CompensationThis person is connected to 5 Board Members in 5 organization across 8 different industries.

See Board Relationships


Dr. Geoffrey F. Cox, also known as Geoff, Ph.D., BSc is a Partner at Red Sky Partners LLC. Dr. Cox serves as an Independent Consultant to the Biotechnology and Life Sciences Industry and Principal of Beacon Street Advisors LLC. Dr. Cox served as the Interim Chief Executive Officer of Novelion Therapeutics Inc. (alternate name: QLT Inc.) from October 23, 2014 to November 29, 2016. He has over 35 years of pharmaceutical and biotechnology experience in a broad range of ...

Corporate Headquarters

2500 Northwinds Parkway
Alpharetta, Georgia 30009

United States

Phone: 678-221-3343
Fax: --

Board Members Memberships

Non-Executive Director
Independent Director
Non-Executive Independent Director
Non Executive Director


University of Birmingham
University of East Anglia

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

Total Annual Cash Compensation$52,375
Total Calculated Compensation$58,315

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


Severin Schwan Chief Executive Officer and Executive Director
Roche Holding AG
Compensation as of Fiscal Year 2016.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Aviragen Therapeutics, Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.